期刊文献+

颞下颌关节上腔封闭—扩张联合灌洗及粘弹补充治疗不可复性关节盘前移位 被引量:1

Intraarticular injection-dilatation and later lavage plus viscosupplementation of TMJ for the treatment of anterior disc displacement without reduction
下载PDF
导出
摘要 目的:评价颞下颌关节上腔封闭-扩张术联合灌洗及粘弹补充疗法治疗不可复性关节盘前移位的临床效果。方法:对29例不可复性关节盘前移位患者行关节上腔封闭-扩张治疗,3~5d后行灌洗术,结束时注入1%透明质酸钠1ml。在治疗的同时配合被动张口训练。以配对t检验对数据进行处理。结果:封闭-扩张术后张口度及健侧侧向运动度较治疗前、灌洗及粘弹补充治疗术后张口度及健侧侧向运动度较灌洗术前均有显著增加(P<0.01),疼痛基本消失。治疗过程中有5例患者出现健侧关节疼痛,经用封闭-扩张治疗后疼痛消失,张口度相应增加3~5mm。结论:(1)颞下颌关节上腔封闭-扩张联合灌洗及粘弹补充疗法能有效改善不可复性关节盘前移位患者的张口度及侧向运动度,缓解关节疼痛。(2)封闭-扩张术与灌洗及粘弹补充疗法两者有互补及累加作用。(3)及时发现对侧关节的隐匿病变并进行治疗,能提高整体疗效。 PURPOSE:To evaluate the clinical efficacy of the TMJ intraarticular injection-dilatation and later lavage plus viscosupplementation as a treatment for anterior disc displacement without reduction of the TMJ. METHODS: 29 patients with anterior disc displacement without reduction of the TMJ were treated by using intraarticular injection-dilatation. Arthrocentesis and lavage was conducted after 3-5 days, a volume of 1ml of sodium hyaluronate was injected into the super cavity at the end of lavage. The passive exercise mouth opening was done twice every day. Paired t test was used for statistical analysis. RESULTS: The maximum mouth opening was increased from (23.66±4.39)mm before treatment to (34.93±4.50)mm after intraarticular injection-dilatation(P<0.01),(39.17±4.38)mm after lavage plus viscosupplementation(P<0.01). The mandibular healthy side direction motion increased significantly (P<0.01) at different periods. 2 patients had mandibular motion pain after a series of treatments. 5 cases had pain on the opposite joints during treatment. CONCLUSION: (1) The TMJ intraarticular injection-dilatation and later lavage plus viscosupplementation is useful for patients with anterior disc displacement without reduction of the TMJ . The new therapy can increase mandibular motion and reduce pain. (2) The TMJ intraarticular injection-dilatation and lavage plus viscosupplementation are complementary and accumulated. (3) The opposite joint's pathological changes that is found and treated can increase the overall effect.
作者 钟伟强 周刚
出处 《上海口腔医学》 CAS CSCD 2004年第1期23-26,共4页 Shanghai Journal of Stomatology
关键词 颞下颌关节 不可复性关节盘前移位 关节上腔封闭-扩张疗法 关节上腔灌洗术 关节上腔粘弹补充疗法 联合治疗 Temporomandibular joint Anterior disc displacement without reduction Intraarticular injection-dilatation Arthrocentesis and lavage Viscosupplementation
  • 相关文献

参考文献6

二级参考文献13

共引文献71

同被引文献11

  • 1Lacey DL, Timms E, Tan HL, et al. Osteoprotegerin (OPG) ligand is a cytokine that regulates osteoelast differentiation and activation[J]. Cell, 1998, 93: 165-176.
  • 2Katagiri T, Takahashi N. Regulatory mechanism of osteoblast and osteoclast differentiation [J]. Oral Disease, 2002,8:147-159.
  • 3Hofbauer LC, Shui C, Riggs BL, et al. Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells [J]. Biochem Biophys Res Commun, 2001,280:334-339.
  • 4Akatsu T, Murakami T, Nishikawa M, et al. Osteoclastogenesis inhibitory factor suppresses osteoclast survival by interfering in the interaction of stromal cells with osteoclast [J]. Biochem Biophys Res Commun, 1998,250:229-234.
  • 5Hsu H, Lacey DL, Dunstan CR, et al. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand [J]. Proc Natl Acad Sci U S A, 1999,96:3540-3345.
  • 6Sugiyama T. Involvement of interleukin-6 and prostaglandin E2 in periarticular osteoporosis of postmenopausal women with rheumatoid arthritis [J]. Rheumatology (Oxford),2001,40:623-630.
  • 7Udagawa N. The mechanism of osteoclast differentiation from macrophages: possible roles of T lymphocytes in osteoclastogenesis[J]. J Bone Miner Metab,2003,21:337-343.
  • 8Lubberts E, van den Bersselaar L, Oppers-Walgreen B, et al. IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance [J]. J Immunol,2003,170(5): 2655-2262.
  • 9Mori H, Kitazawa R, Mizuki S, et al. RANK ligand, RANK, and OPG expression in type Ⅱ collagen-induced arthritis mouse [J].Histochem Cell Biol,2002,117: 283-292.
  • 10Suda T, Takahashi N, Udagawa N, et al. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families [J]. Errdocrine Res,1999,20:345-357.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部